Who has invested in Epigenic Therapeutics?

Lapam Capital, Qiming Venture Partners, OrbiMed, IFSC, Morningside Venture Capital are named among the investors backing Epigenic Therapeutics.

Epigenic Therapeutics Funding: $92M Raised, Series B (2025)

Epigenic Therapeutics funding overview

Epigenic Therapeutics is a Biotech company based in San Diego, California. Epigenic Therapeutics has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2025. The round record for Epigenic Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Lapam Capital, Qiming Venture Partners, OrbiMed, IFSC, Morningside Venture Capital. 5 distinct backers are named across the disclosed rounds.

Epigenic Therapeutics at a glance

Total raised: $92M
Latest round: Series B
Latest round date: September 2025
Industry: Biotech
Headquarters: San Diego, California
Notable investors: Lapam Capital, Qiming Venture Partners, OrbiMed, IFSC, Morningside Venture Capital

Frequently asked about Epigenic Therapeutics funding

How much has Epigenic Therapeutics raised?: Epigenic Therapeutics has raised $92M in total disclosed funding across the rounds on record.
Who has invested in Epigenic Therapeutics?: Lapam Capital, Qiming Venture Partners, OrbiMed, IFSC, Morningside Venture Capital are named among the investors backing Epigenic Therapeutics.
What was the latest Epigenic Therapeutics funding round?: The most recent disclosed round is a Series B, announced in September 2025.
Where is Epigenic Therapeutics based?: Epigenic Therapeutics is based in San Diego, California.
What sector does Epigenic Therapeutics operate in?: Epigenic Therapeutics is tracked under Biotech from San Diego, California, with $92M in disclosed funding.
When did Epigenic Therapeutics last raise?: The last disclosed Epigenic Therapeutics round closed in September 2025 at Series B.

Round data for Epigenic Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Diego and backer lists below.

Epigenic Therapeutics Funding: $92M Raised, Series B (2025)

Epigenic Therapeutics funding overview

Epigenic Therapeutics at a glance

Frequently asked about Epigenic Therapeutics funding

Companies related to Epigenic Therapeutics (40)

Browse related funding lists (7)